Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | TAR | Masanori Fujimoto | ||||||
GSE189285 |
Liver ILC2s suppress gluconeogenesis and limit blood glucose elevation through IL-13 signaling [scRNA-seq_ILC2]
|
4 |
|
Masanori Fujimoto | Jul 27, 2022 | |||
GSE189286 |
Liver ILC2s suppress gluconeogenesis and limit blood glucose elevation through IL-13 signaling [scRNA-seq_Hepatocyte]
|
2 |
|
Masanori Fujimoto | Jul 27, 2022 | |||
GSE189287 |
Liver ILC2s suppress gluconeogenesis and limit blood glucose elevation through IL-13 signaling
|
30 |
|
Masanori Fujimoto | Jul 27, 2022 | |||
GSE214508 |
MicroRNA-874 targets phosphomevalonate kinase and inhibits cancer cell growth via the mevalonate pathway [scRNA-seq]
|
4 | Masanori Fujimoto | Oct 03, 2022 | ||||
GSE214509 |
MicroRNA-874 targets phosphomevalonate kinase and inhibits cancer cell growth via the mevalonate pathway
|
22 |
|
Masanori Fujimoto | Oct 03, 2022 |